Atypical neuroleptic malignant syndrome associated with aripiprazole [3]

Journal of Clinical Psychopharmacology

Volumn 26, Issue 5, 2006, Pages 534-

  Kang, Seung Gul ^a   Lee, Heon Jeong ^a   Lee, Min Soo ^a   Kim, Leen ^a   Park, Jae Seok ^b  

^a Korea University Ansan Hospital   (South Korea)

^b Miryang Hansol Hospital   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; BENZATROPINE; FLUNITRAZEPAM; HALOPERIDOL; LORAZEPAM; OLANZAPINE; PROPRANOLOL;

ADULT; AKATHISIA; CASE REPORT; CATATONIA; CLINICAL FEATURE; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; DISEASE COURSE; FOLLOW UP; HUMAN; INSOMNIA; LABORATORY TEST; LETTER; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; HUMANS; MALE; NEUROLEPTIC MALIGNANT SYNDROME; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA;

EID: 33748753312     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.jcp.0000237948.88387.d7     Document Type: Letter

References (2)

1. Duggal HS, Kithas J. Possible neuroleptic malignant syndromewith aripiprazole and fluoxetine. Am J Psychiatry. 2005;162(2):397-398.
2. Buckley PF. Aripiprazole: efficacy and tolerability profile of a novel-acting atypical antipsychotic. Drugs Today (Barc). 2003;39:145-151.